Effect of Cinacalcet on Cardiovascular Disease in Patients …
Dec 27, 2012 · It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients.
Dr Reddy's recalls over 330k bottles of generic drug in US: USFDA
2 days ago · The recall is due to the "presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", it added. New Jersey-based Dr Reddy's Laboratories, Inc., a unit of Hyderabad-based drug major, is recalling 2,85,126 bottles of Cinacalcet tablets in 30 mg strength. Besides, the drug maker is recalling 35,880 and 10,584 bottles of 60 mg ...
Dr Reddy's Labs recalls over 3 lakh bottles of Cinacalcet tablets in …
22 hours ago · As per PTI, New Jersey-based Dr Reddy's Laboratories, Inc., a unit of Hyderabad-based drug major, is recalling 2,85,126 bottles of Cinacalcet tablets in 30 mg strength. Besides, the drug maker is recalling 35,880 and 10,584 bottles of 60 mg and 90 mg strengths, respectively, USFDA said. The affected lot has been produced in India, it added.
Cinacalcet Does Not Up Risk for Severe Gastrointestinal Bleeding …
Aug 6, 2021 · Cinacalcet use does not increase the risk for severe gastrointestinal bleeding that leads to hospitalization or death, according to results from an FDA-mandated postmarketing study.
Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic ...
Nov 17, 2014 · We can speculate that the potential cardiovascular benefit of cinacalcet in the context of hemodialysis may be mediated via nonatherosclerotic disease mechanisms, for example, slowing of arterial calcification or reducing myocardial calcium accumulation. Our data suggest that treatment with cinacalcet may reduce the risk of cardiovascular death.
Cinacalcet - StatPearls - NCBI Bookshelf
Feb 24, 2024 · Cinacalcet, a calcimimetic that mitigates the increase in PTH, is increasingly taking center stage. When formulating a multi-modal approach for conditions such as calciphylaxis, CKD, and hyperparathyroidism, this medication …
Cinacalcet May Help Relieve Calciphylaxis - Renal and Urology News
Feb 9, 2019 · Immediate cinacalcet therapy may help improve calciphylaxis outcomes in patients with stage 4 to 5 chronic kidney disease (CKD) and calciphylaxis.
Cinacalcet (Sensipar): Uses & Side Effects - Cleveland Clinic
Cinacalcet is a medication that treats chronic kidney disease (dialysis) and high levels of calcium in your blood if you have parathyroid gland conditions. This medication comes in a tablet form that you can take by mouth with a glass of water.
Cinacalcet (oral route) - Mayo Clinic
Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH).
Cinacalcet - Memorial Sloan Kettering Cancer Center
Dec 12, 2022 · This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.